TMCnet News
Forty Seven Inc. to Present at the Credit Suisse 27th Annual Healthcare ConferenceMENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV) a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced that Mark McCamish, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the Credit Suisse 27th Annual Healthcare Conference on Wednesday, November 14, 2018 at 4:00 p.m. MT (6:00 p.m. ET) in Scottsdale, AZ. A live webcast of the presentation will be available under “Events & Presentations” in the Investors section of the Company’s website at www.fortyseveninc.com. A replay of the webcast will be available on the Forty Seen website for 90 days following the event. About Forty Seven Inc.: For more information, please visit www.fortyseveninc.com or contact [email protected]. For journalist inquiries, please contact Sarah Plumridge at [email protected] or phone (312) 506-5218. For investor inquiries, please contact Hannah Deresiewicz at Stern Investor Relations Inc. at [email protected] or phone (212) 362-1200. |